[ MICHAEL J. FOX FOUNDATION - Therapeutic Pipeline Program | Research funding ]
Event details
| Date | 24.09.2019 |
| Category | Call for proposal |
Aim: The Michael J. Fox Foundation (MJFF) funds research to better define, measure, and treat Parkinson’s disease and supports the development of critical tools and other resources to advance that research.
The Therapeutic Pipeline Program seeks to speed the development of Parkinson’s disease therapeutics with potential for fundamentally altering disease course and/or significantly improving treatment or management of symptoms beyond current standards of care. Proposals should focus on strategies with clear impact for people with Parkinson’s and well-defined development plans. Programs developing novel approaches as well as approved or clinically safe repurposed or repositioned therapies from other disease indications are appropriate. MJFF will prioritize approaches built on strong scientific and biological rationale for targeting fundamental processes underlying Parkinson’s cause, progression and/or symptom expression.
Funding: Maximum USD $500’000 (preclinical)
Maximum USD $2’000’000 (clinical)
Duration: 1-2 years (pre-clinical)
2-3 years (clinical)
Eligibility: Researchers at all academic levels at or above Assistant Professor are eligible to apply.
How to Apply: The pre-proposal is the first step in the application. Pre-proposals must be completed in the online application portal. Successful applicants will be given further instructions for submitting a full proposal.
Deadline (Pre-proposal): 24 September 2019 (5:00 pm EST)
Deadline (Full Application, by invitation): 17 January 2020 (5:00 pm EST)
Further information
The Therapeutic Pipeline Program seeks to speed the development of Parkinson’s disease therapeutics with potential for fundamentally altering disease course and/or significantly improving treatment or management of symptoms beyond current standards of care. Proposals should focus on strategies with clear impact for people with Parkinson’s and well-defined development plans. Programs developing novel approaches as well as approved or clinically safe repurposed or repositioned therapies from other disease indications are appropriate. MJFF will prioritize approaches built on strong scientific and biological rationale for targeting fundamental processes underlying Parkinson’s cause, progression and/or symptom expression.
Funding: Maximum USD $500’000 (preclinical)
Maximum USD $2’000’000 (clinical)
Duration: 1-2 years (pre-clinical)
2-3 years (clinical)
Eligibility: Researchers at all academic levels at or above Assistant Professor are eligible to apply.
How to Apply: The pre-proposal is the first step in the application. Pre-proposals must be completed in the online application portal. Successful applicants will be given further instructions for submitting a full proposal.
Deadline (Pre-proposal): 24 September 2019 (5:00 pm EST)
Deadline (Full Application, by invitation): 17 January 2020 (5:00 pm EST)
Further information
- See the official webpage for more details, or download the RFA
- Find the application portal here
- Participate in the MJFF funding opportunities webinar on 12 September to learn more
Practical information
- General public
- Free